TP53 and breast carcinoma: In this study we utilized RNAi toknockdown HdmX or Hdm2 in MCF7 human breast cancer cells, which harborwild-type p53 and elevated levels of HdmX and Hdm2 then examined geneexpression changes and effects on cell growth.